# Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma

> **NCT02798510** · PHASE3 · UNKNOWN · sponsor: **Fudan University** · enrollment: 140 (estimated)

## Conditions studied

- Malignant Neoplasm Other Gallbladder/Extrahepatic Bile Duct

## Interventions

- **RADIATION:** Concurrent Chemoradiotherapy
- **DRUG:** capecitabine
- **DRUG:** gemcitabine

## Key facts

- **NCT ID:** NCT02798510
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2019-04
- **Final completion:** —
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2016-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02798510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02798510, "Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02798510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*